KURA - Kura Oncology, Inc.
IEX Last Trade
8.97
-0.080 -0.892%
Share volume: 30,229
Last Updated: Thu 26 Dec 2024 08:30:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$9.05
-0.08
-0.88%
Summary score
24%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
23%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.65%
Return on assets
-9.47%
Return on sales
0%
Return on invested capital
163.79%
Total debt ratio
12.96%
Debt ratio change over timeo
-0.92%
Current Ratio
14.48%
Quick Ratio
0%
Cash Position Ratio
2.91%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.75%
Return on assets
-7.42%
Return on sales
0%
Return on invested capital
187.89%
Total debt ratio
9.2%
Debt ratio change over timeo
-0.94%
Current Ratio
17.08%
Quick Ratio
0%
Cash Position Ratio
3.86%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-6.36%
Return on assets
-6%
Return on sales
0%
Return on invested capital
264.79%
Total debt ratio
8.68%
Debt ratio change over time
-0.96%
Current Ratio
18.45%
Quick Ratio
0%
Cash Position Ratio
7.26%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-106.94%
Return on assets
-106.24%
Return on sales
0%
Return on invested capital
6.64%
Total debt ratio
-91.77%
Debt ratio change over time
-0.92%
Current Ratio
8.65%
Quick Ratio
0%
Cash Position Ratio
0.94%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KURA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.65% | -3.05% | 11.55% | 6.27% |
| Return on assets | -9.47% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 163.79% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 12.96% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.92% | 6.09% | 6.03% | 1.53% |
| Dept financing | 3% | 50% | 43% | 14% |
| Current Ratio | 17.08% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.86% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 19% | 36% | 40% |
| Short-term ratios | KURA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -7.75% | -25.62% | 17.94% | 7.14% |
| Return on assets | -7.42% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 187.89% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 60% |
| Total debt ratio | 9.2% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.94% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 17.08% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.86% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 30% | 23% | 40% |